Insomnia
Therapeutic area
Neurology
Rare disease
No
- Definition
- A sleep disorder characterized by difficulty in falling asleep and/or remaining asleep.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Insomnia
- Therapeutic area
- Neurology
- insomnia
- insomnia
- insomnia (disease)
- DSPD
- DSPS
- delayed sleep phase syndrome, susceptibility to
- All therapeutic areas
- Neurology
- Severity
- Mild
- MONDO ID
- MONDO:0013600
- Parent condition
- MONDO:0005560
Related records
Broader conditions (8)
- Brain disorder
- Central nervous system disorder
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Human disease
- Nervous system disorder
- Sleep disorder
Narrower conditions (1)
- Fatal familial insomnia
Trials (1,421)
- 'Mindfulness-Based Joyful Sleep' Intervention in Young and Middle-aged Individuals With Insomnia
- 2-Year Study of Vagus Nerve Stimulation for Higher-Grade Treatment-Resistant Depression: Clinical Outcomes and Policy Recommendation
- 4-7-8 Breathing for Fatigue and Sleep Management in Hemodialysis
- 40 Hz Flickering for Insomnia in Parkinson's Disease
- 40 Hz Light Neurostimulation for Patients With Depression (FELIX)
- A 2-Part Single Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006
- A Behavioral Therapy for Insomnia Co-existing With COPD
- A Bioequivalence and Food Effect Study of SEP-190 in Japanese Healthy Subjects (Study SEP 190-102)
- A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD
- A Brief Behavioral Sleep Intervention for Depression Among Military Veterans
- A Brief Parent-based Sleep Intervention for ADHD Children
- A Brief Parent-based Sleep Intervention for Children With Autism Spectrum Disorder
- A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression
- A Clinical Study of Theta Burst Stimulation (cTBS) in the Treatment of Insomnia Disorder Targeting the Dentate Nucleus of the Cerebellum
- A Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate Tablets
- A Clinical Study to Evaluate the Pharmacokinetic Profile of SB-649868 in Elderly and Female Population
- A Clinical Trial of De-Stress & Snooze Gummies in Reducing Stress and Insomnia Disorder
- A Clinical Trial to Evaluate the Effects of EMF Protection Devices on Sleep and Energy Levels
- A Cognitive-Behaviour Therapy (CBT) Self-Management Approach for Insomnia in Chronic Pain: A Randomized Control Trial
- A Comparison of CBTi and Usual Treatment for Tinnitus Related Insomnia
Approved drugs (17)
- Daridorexant hydrochloride
- Diphenhydramine hydrochloride
- Doxepin hydrochloride
- Estazolam
- Eszopiclone
- Flurazepam hydrochloride
- Lemborexant
- Melatonin
- Mirtazapine
- Pentobarbital
- Quazepam
- Ramelteon
- Suvorexant
- Temazepam
- Triazolam
- Zaleplon
- Zolpidem tartrate
Drugs in development (44)
- Adipiplon Phase 2
- Almorexant Phase 3
- Amitriptyline Phase 3
- Armodafinil Phase 2
- Aspirin Early phase 1
- Atagabalin Phase 2
- Brotizolam Phase 3
- Cannabidiol Phase 3
- Cannabinol Phase 2
- Casopitant Phase 2
- Charcoal, activated Phase 1
- Daridorexant Phase 3
- Dexmedetomidine Phase 3
- Dimdazenil Phase 2
- Eplivanserin Phase 3
- Esmirtazapine Phase 3
- Esmirtazapine maleate Phase 3
- Fazamorexant Phase 3
- Filorexant Phase 2
- Flumazenil Phase 1
Other linked drugs (20)
- Amobarbital
- Aprobarbital
- Barbital
- Butabarbital
- Carphenazine
- Ethchlorvynol
- Ethinamate
- Flunitrazepam
- Glutethimide
- Lidocaine hydrochloride
- Methaqualone
- Methyprylon
- Midazolam
- Nabilone
- Nitrazepam
- Obeticholic acid
- Paraldehyde
- Pipamperone
- Propiomazine
- Triclofos sodium